Interested in writing for CW? Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.

In a new tactic, the Justice Department this week instructed federal prosecutors to build criminal drug cases against Mexican officials using terrorism statutes. By Ernesto Londoño Alan Feuer and Jack ...

Artificial intelligence, commercial-first buying and demands for proof of returns on investment are rewriting the rules for contractors, writes GovExec CEO Tim Hartman. The old assumptions are no ...

From a COO’s perspective, operational breakdowns at scale are less about execution and more about how the organization is designed to operate. Operational excellence built on shared context and ...

ACT Expo 2026 highlighted a shift from regulation-driven electric truck deployment to a measured, diversified sustainability approach as emission rules and incentives were rolled back. With federal ...

May 6 (Reuters) - Microsoft (MSFT.O), opens new tab is considering delaying or abandoning its 2030 goal of matching its entire hourly electricity use with renewable energy purchases, Bloomberg News ...

Most credit card issuers don't classify Walmart and Target as grocery stores, meaning they often don't qualify for high-earning grocery rewards categories. To earn significant rewards at Walmart and ...

The latest trends in software development from the Computer Weekly Application Developer Network. Traditionally a favourite technology conference that draws in press and swathes of coders, fans of IBM ...

IBM Corp. will use its Think 2026 conference today to outline a broad expansion of its enterprise artificial intelligence portfolio, positioning a new “AI operating model” as the next stage in its ...

Western Digital (NASDAQ:WDC | WDC Price Prediction) stock just received its most aggressive price target raise of the cycle. Citi lifted its price target to $500 from $405, maintaining a Buy rating, ...

“In the first quarter, we delivered over $100 million in combined sales of Revuforj and Niktimvo, underscoring robust demand for both medicines and advancing the company towards profitability,” said ...